Kura Oncology (KURA) Institutional Ownership

Of the 181 institutional investors that purchased Kura Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($5.19M), RA Capital Management L.P. ($4.45M), Jacobs Levy Equity Management Inc. ($2.67M), AQR Capital Management LLC ($1.67M), State Street Corp ($1.59M), EcoR1 Capital LLC ($1.56M), and Millennium Management LLC ($1.52M).

Institutional investors have bought a total of 20,465,019 shares in the last 24 months. This purchase volume represents approximately $177.97M in transactions.

Of the 65 institutional investors that sold Kura Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Armistice Capital LLC ($1.90M), Franklin Resources Inc. ($1.34M), Millennium Management LLC ($1.04M), Assenagon Asset Management S.A. ($925.32K), Goldman Sachs Group Inc. ($811.77K), TCG Crossover Management LLC ($688.46K), and Prosight Management LP ($651.58K).

Institutional investors have sold a total of 12,192,605 shares in the last 24 months. This volume of shares sold represents approximately $102.06M in transactions.